Together, the results demonstrate a suppressive role of miR-29c by targeting the TIMP3/STAT1/FOXO1 pathway in breast cancer cell proliferation, migration and invasion, and suggest that the loss of miR-29c might be a novel biomarker related to the progression of breast cancer. The gene discussed is TIMP3; the disease is breast cancer.